A rendering of Amgen's new science and innovation center in Thousand Oaks. (courtesy photo) Thousand Oaks-based Amgen, one of the largest biotech companies in the world, upped its fiscal guidance for the year after the company reported strong drug sales in the second quarter of 2026. Released after the markets closed Aug. 4, Amgen reported…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
